These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 7678030

  • 1. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ, van Kessel KP, van den Tol ME, van Strijp JA, Torensma R, Verhoef J, Elsbach P, Weiss J.
    J Immunol; 1993 Jan 01; 150(1):253-63. PubMed ID: 7678030
    [Abstract] [Full Text] [Related]

  • 2. Modulation of lipopolysaccharide binding to human granulocytes.
    Weersink AJ, Van Kessel KP, Van der Tol ME, Verhoef J.
    Immunology; 1994 Dec 01; 83(4):617-23. PubMed ID: 7533136
    [Abstract] [Full Text] [Related]

  • 3. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF, Dentener MA, Buurman WA.
    J Immunol; 1994 May 15; 152(10):5070-6. PubMed ID: 7513728
    [Abstract] [Full Text] [Related]

  • 4. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA, Kalatzis ES, Weiss J, Elsbach P.
    J Immunol; 1989 Apr 15; 142(8):2807-12. PubMed ID: 2539411
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 6. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA.
    J Immunol; 1993 Oct 15; 151(8):4258-65. PubMed ID: 8409400
    [Abstract] [Full Text] [Related]

  • 7. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR, Lamping N, Hoess A.
    J Immunol; 1997 Dec 01; 159(11):5599-605. PubMed ID: 9548502
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased bactericidal/permeability increasing protein in patients with cirrhosis.
    Guerra-Ruiz A, Casafont F, Cobo M, Terán A, de-la-Peña J, Estebanez A, Pons-Romero F.
    Liver Int; 2010 Jan 01; 30(1):94-101. PubMed ID: 19765220
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ.
    J Immunol; 1993 Apr 01; 150(7):3011-21. PubMed ID: 7681085
    [Abstract] [Full Text] [Related]

  • 12. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P, Weiss J, Doerfler M, Shu C, Kohn F, Ammons WS, Kung AH, Meszaros KK, Parent JB.
    Prog Clin Biol Res; 1994 Apr 01; 388():41-51. PubMed ID: 7831373
    [Abstract] [Full Text] [Related]

  • 13. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun 01; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 14. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R, Marra MN, McKelligon BM, Lonnemann G, Schulzeck P, Schulze M, Oppermann M, Shaldon S.
    Clin Nephrol; 1993 Dec 15; 40(6):346-51. PubMed ID: 7507806
    [Abstract] [Full Text] [Related]

  • 16. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ, van der Tol ME, Van Kessel KP, Verhoef J, Van Strijp JA.
    J Immunol; 1998 Oct 01; 161(7):3607-15. PubMed ID: 9759883
    [Abstract] [Full Text] [Related]

  • 17. Interaction between CD14 lipopolysaccharide binding protein and bactericidal/permeability-increasing protein during lipopolysaccharide-induced cell activation.
    Dentener MA, Von Asmuth EJ, Francot GJ, Buurman WA.
    Prog Clin Biol Res; 1994 Oct 01; 388():59-70. PubMed ID: 7530372
    [No Abstract] [Full Text] [Related]

  • 18. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.
    Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC.
    J Immunol; 1998 Sep 01; 161(5):2552-60. PubMed ID: 9725255
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.